Media coverage
16
Media coverage
Title Salarius Pharmaceuticals Adds Fox Chase Cancer Center To Ongoing Trial Of Seclidemstat As A Treatment For Ewing Sarcoma And FET-Rearranged Sarcomas Media name/outlet TheStreet.com Country/Territory United States Date 07/13/21 URL https://www.thestreet.com/press-releases/salarius-pharmaceuticals-adds-fox-chase-cancer-center-to-ongoing-trial-of-seclidemstat-as-a-treatment-for-ewing-sarcoma-and-fet-rearranged-sarcomas-15709428 Persons Johnathan R. Whetstine, Margaret von Mehren Title Salarius Pharmaceuticals Adds Fox Chase Cancer Center to Ongoing Trial of Seclidemstat as a Treatment for Ewing Sarcoma and FET-Rearranged Sarcomas Media name/outlet Morningstar.com Country/Territory United States Date 07/13/21 URL https://www.morningstar.com/news/globe-newswire/8279118/salarius-pharmaceuticals-adds-fox-chase-cancer-center-to-ongoing-trial-of-seclidemstat-as-a-treatment-for-ewing-sarcoma-and-fet-rearranged-sarcomas Persons Johnathan R. Whetstine, Margaret von Mehren Title Salarius Pharmaceuticals Adds Fox Chase Cancer Center to Ongoing Trial of Seclidemstat as a Treatment for Ewing Sarcoma and F... Media name/outlet ADVFN UK Country/Territory United Kingdom Date 07/13/21 URL https://uk.advfn.com/stock-market/NASDAQ/SLRX/share-news/Salarius-Pharmaceuticals-Adds-Fox-Chase-Cancer-Cen/85573781 Persons Johnathan R. Whetstine, Margaret von Mehren Title Salarius Pharmaceuticals Adds Fox Chase Cancer Center to Ongoing Trial of Seclidemstat as a Treatment for Ewing Sarcoma and FET-Rearranged Sarcomas Media name/outlet Yahoo! Finance Country/Territory United States Date 07/13/21 URL https://finance.yahoo.com/news/salarius-pharmaceuticals-adds-fox-chase-113300462.html Persons Johnathan R. Whetstine, Margaret von Mehren Title SALARIUS PHARMACEUTICALS : Adds Fox Chase Cancer Center to Ongoing Trial of Seclidemstat as a Treatment for Ewing Sarcoma and FET-Rearranged Sarcomas Media name/outlet MarketScreener.com Country/Territory United States Date 07/13/21 URL https://www.marketscreener.com/quote/stock/SALARIUS-PHARMACEUTICALS-62465383/news/Salarius-Pharmaceuticals-nbsp-Adds-Fox-Chase-Cancer-Center-to-Ongoing-Trial-of-Seclidemstat-as-a-T-35845399/ Persons Johnathan R. Whetstine, Margaret von Mehren Title Salarius Pharmaceuticals Adds Fox Chase Cancer Center to Ongoing Trial of Seclidemstat as a Treatment for Ewing Sarcoma and FET-Rearranged Sarcomas Media name/outlet Chase Country/Territory United States Date 07/13/21 URL https://idc.chase.com/newspublic/story?article=44b5be151f69217d&module=default Persons Johnathan R. Whetstine, Margaret von Mehren Title Salarius Pharmaceuticals Adds Fox Chase Cancer Center to Ongoing Trial of Seclidemstat as a Treatment for Ewing Sarcoma and FET-Rearranged Sarcomas Media name/outlet Stockwatch Country/Territory Canada Date 07/13/21 URL www.stockwatch.com/News/Item/U-z8279118-U!SLRX-20210713/U/SLRX Persons Johnathan R. Whetstine, Margaret von Mehren Title Salarius Pharmaceuticals Adds Fox Chase Cancer Center to Ongoing Trial of Seclidemstat as a Treatment for Ewing Sarcoma and FET-Rearranged Sarcomas Media name/outlet TD Ameritrade Country/Territory United States Date 07/13/21 URL https://research.tdameritrade.com/grid/public/markets/news/story.asp?fromPage=results&docKey=100-194u9097 Persons Johnathan R. Whetstine, Margaret von Mehren Title Salarius Pharmaceuticals Adds Fox Chase Cancer Center to Ongoing Trial of Seclidemstat as a Treatment for Ewing Sarcoma and F... Media name/outlet ADVFN US Country/Territory United States Date 07/13/21 URL https://www.advfn.com/p.php?pid=nmona&article=85573781 Persons Johnathan R. Whetstine, Margaret von Mehren Title Salarius Pharmaceuticals Adds Fox Chase Cancer Center to Ongoing Trial of Seclidemstat as a Treatment for Ewing Sarcoma and FET-Rearranged Sarcomas Media name/outlet Spoke.com Country/Territory United States Date 07/13/21 URL https://www.spoke.com/press_releases/60ed7e2f305335cc2201abe5 Persons Johnathan R. Whetstine, Margaret von Mehren Title Salarius Pharmaceuticals Adds Fox Chase Cancer Center to Ongoing Trial of Seclidemstat as a Treatment for Ewing Sarcoma and FET-Rearranged SarcomasClinical Trial Now Expands to Nine U.S. Trial Sites Media name/outlet BioSpace Country/Territory United States Date 07/13/21 URL https://www.biospace.com/article/releases/salarius-pharmaceuticals-adds-fox-chase-cancer-center-to-ongoing-trial-of-seclidemstat-as-a-treatment-for-ewing-sarcoma-and-fet-rearranged-sarcomasclinical-trial-now-expands-to-nine-u-s-trial-sites/?s=95 Persons Johnathan R. Whetstine, Margaret von Mehren Title Adds Fox Chase Cancer Center to Ongoing Trial of Seclidemstat as a Treatment for Ewing Sarcoma and FET Rearranged Sarcomas Media name/outlet Market News Publishing Country/Territory United States Date 07/13/21 Persons Johnathan R. Whetstine, Margaret von Mehren Title Salarius Pharmaceuticals Adds Fox Chase Cancer Center to Ongoing Trial of Seclidemstat as a Treatment for Ewing Sarcoma and FET-Rearranged Sarcomas Media name/outlet FirstWord Pharma Country/Territory United States Date 07/13/21 URL www.firstwordpharma.com/node/1845472 Persons Johnathan R. Whetstine, Margaret von Mehren Title Salarius Pharmaceuticals Adds Fox Chase Cancer Center to Ongoing Trial of Seclidemstat as a Treatment for Ewing Sarcoma and FET-Rearranged Sarcomas Media name/outlet GlobeNewswire Country/Territory United States Date 07/13/21 URL https://www.globenewswire.com/news-release/2021/07/13/2261828/0/en/Salarius-Pharmaceuticals-Adds-Fox-Chase-Cancer-Center-to-Ongoing-Trial-of-Seclidemstat-as-a-Treatment-for-Ewing-Sarcoma-and-FET-Rearranged-Sarcomas.html Persons Johnathan R. Whetstine, Margaret von Mehren Title Salarius Pharmaceuticals Adds Fox Chase Cancer Center to Ongoing Trial of Seclidemstat as a Treatment for Ewing Sarcoma and FET-Rearranged Sarcomas Media name/outlet BizWire Express Country/Territory India Date 07/13/21 URL www.bizwireexpress.com/showstoryGNW.php?storyid=222210 Persons Johnathan R. Whetstine, Margaret von Mehren Title Salarius Pharmaceuticals Adds Fox Chase Cancer Center to Ongoing Trial of Seclidemstat as a Treatment for Ewing Sarcoma and FET-Rearranged Sarcomas; Clinical Trial Now Expands to Nine U.S. Trial Sites Media name/outlet PrimeNewswire (Top News) Country/Territory United States Date 07/13/21 Persons Johnathan R. Whetstine, Margaret von Mehren